The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
among universities worldwide for producing undergrad entrepreneurs
in Israel and Europe for research on artificial intelligence
of the student body are women
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
In this newly released podcast, Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion – Israel Institute of Technology, dives into the next frontier of health care: disease modeling. He explains how CytoReason transforms today’s overwhelming biological data into actionable insights that power smarter, faster drug development for leading pharma and biotech companies.
Shai’s work sits at the heart of a global shift toward data-driven medicine. Disease modeling is reshaping how therapies are discovered, tested, and brought to patients — and Technion researchers like Shai are helping lead that transformation.
Shai serves as the director of the Technion’s Healthy Aging Institute, a multidisciplinary effort uniting researchers to understand the science of aging and extend the years of healthy, active life. His systems-immunology expertise plays a critical role in uncovering how our immune system changes over time, and how science can intervene.
Podcast credit: Technion Alumni Association.
November 20, 2025
Learn how Technion Prof. Shai Shen-Orr's disease modeling research contributes to the discovery of innovative therapeutic strategies.
2 mins
X (opens in a new tab) / Facebook (opens in a new tab) / LinkedIn (opens in a new tab) / Email / Copy Link
Healthy Aging / Biotech / Faculty / Heart Health / Intelligent Drugs /
The Nobel Assembly at Karolinska Institutet announced Monday that professors Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Medicine, with two of the three laureates having received the Technion-Israel Institute of Technology Harvey Prize. Prof. Deisseroth of the Howard Hughes Medical Institute and Stanford University, USA, and Prof. Hegemann […]
A breast cancer diagnosis can bring a terrifying question: Will chemotherapy save my life, or will I endure its painful side effects without any benefit? In this video, influencer Aija Mayrock goes inside the Technion – Israel Institute of Technology with Dr. Gil Shamai to explore an AI breakthrough that could help doctors answer that […]
A Breakthrough From the Technion Together with collaborators from leading medical centers in Israel, the United States, Europe, and Australia, Shamai and his team at the Technion have developed an AI model that predicts both the risk that breast cancer will return and whether a patient is likely to benefit from chemotherapy — offering a […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.